Clin2
NCT06868888Possibly a fitRecruiting

Red blood cell function in kidney failure

End-stage Renal Disease (ESRD)

Treatments studied

Part of Kidney & urinary, Women’s health & pregnancy clinical trials.

This study looks at how red blood cells work in people with end-stage kidney disease who are on hemodialysis. It aims to understand blood flow and may help guide future treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
20 years and older
Study type
Observational

Who can take part

  • Must be receiving hemodialysis and related medications for at least 6 weeks
  • Must have a Kt/V score greater than 1.2 (a measure of dialysis adequacy)
  • Must be 20 years of age or older
  • No severe high potassium (hyperkalemia) in the last 3 months
  • No bone, joint, or muscle problems that make exercise difficult
  • Not pregnant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06575634Recruiting
Exercise and blood cell health in dialysis patients

This study tests whether adding a personalized exercise program to regular dialysis can improve how well your red blood cells move and work. It may help people on dialysis feel better and have healthier blood.

Taoyuan
NCT06233838Recruiting
Hemoperfusion study for kidney patients on dialysis

This trial tests a special blood-filtering treatment (hemoperfusion) for people with advanced kidney disease on regular dialysis. It aims to remove harmful substances that standard dialysis may not fully clear.

Fuzhou, Fujian
NCT07180888Not yet recruiting
Heart function study in kidney dialysis patients

This study looks at how well the heart's pumping and relaxing function works in people with end-stage kidney disease who are on hemodialysis. It may help doctors understand heart problems better in this group.

NCT06983756Not yet recruiting
Erythropoietin for Anemia in Dialysis Patients

This study looks at how well erythropoietin (a drug that helps your body make red blood cells) works for people with end-stage kidney disease who are on regular hemodialysis. It also checks if metabolic syndrome (a group of conditions like high blood sugar, high blood pressure, and extra belly fat) affects how well this drug works.

NCT06587997Not yet recruiting
Kidney blood flow during dialysis in new dialysis patients

This study looks at how blood flow to the kidneys changes during hemodialysis in people who have just started dialysis. It may help doctors understand how to better protect kidney function.

NCT07319468Not yet recruiting
Exercise during dialysis for kidney patients

This trial tests if doing exercises while on hemodialysis can help people with end-stage kidney disease. It is for patients aged 50-60 who have been on dialysis for at least 3 months.

Hear when a new End-stage Renal Disease (ESRD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.